Australian Institute of Health and Welfare (2022) Dementia in Australia, AIHW, Australian Government, accessed 08 October 2022.
Australian Institute of Health and Welfare. (2022). Dementia in Australia. Retrieved from https://www.aihw.gov.au/reports/dementia/dementia-in-aus
Dementia in Australia. Australian Institute of Health and Welfare, 16 September 2022, https://www.aihw.gov.au/reports/dementia/dementia-in-aus
Australian Institute of Health and Welfare. Dementia in Australia [Internet]. Canberra: Australian Institute of Health and Welfare, 2022 [cited 2022 Oct. 8]. Available from: https://www.aihw.gov.au/reports/dementia/dementia-in-aus
Australian Institute of Health and Welfare (AIHW) 2022, Dementia in Australia, viewed 8 October 2022, https://www.aihw.gov.au/reports/dementia/dementia-in-aus
Get citations as an Endnote file:
PDF | 13.3Mb
In 2019–20, 8 in 10 people (82%) who were dispensed script/s for dementia-specific medications were prescribed at least 1 script by a general practitioner (GP). In addition, 38% were prescribed by other medical specialists and less than 1% were prescribed by allied health professionals (for example, nurse practitioners).
The majority (78%) of people who were dispensed dementia-specific medications were prescribed these by 1 type of prescriber. However, as people can receive prescriptions for multiple dementia-specific medications throughout the year, they could be prescribed these by different types of prescribers (for example, prescribed once by a GP and once by a geriatrician). Just over 22% of people who were dispensed scripts for dementia specific medications received these scripts from 2 different types of prescribers and just 0.1% received prescriptions from 3 different types of prescribers. Of the people who were prescribed dementia-specific medications by at least 2 types of prescribers, the majority (98%) were prescribed by a GP and another medical specialist (Table S8.14).
Other than GPs, people were most commonly prescribed dementia-specific medications by specialists in geriatric medicine (23% of people who were dispensed a script for dementia-specific medications that year), followed by neurology (5.3%), psychiatry (4.5%) and internal medicine (3.8%) (Figure 8.9).
There was little difference in the prescribing patterns for men and women. However, patterns varied for people with younger onset dementia. As these people are younger and less likely to see a doctor with a specialisation in geriatric medicine, a greater proportion of dementia-specific medicines were prescribed by specialists in neurology (16%) and psychiatry (9.7%) than they were for people aged 65 and over (4.9% and 4.3%, respectively).
Figure 8.9 is a bar graph showing the percentage of people who were dispensed dementia-specific medications in 2019–20, by age and sex and by the prescribers’ medical specialty (excluding GPs). Almost one-quarter were prescribed dementia-specific medications by geriatricians. A much smaller percentage were prescribed by neurologists (5.3%) and psychiatrists (4.5%). There was little difference between men and women but younger people were more likely to be prescribed dementia-specific medicines by neurologists (16%) and psychiatrists (9.7%) than people aged 65 years or more.
We'd love to know any feedback that you have about the AIHW website, its contents or reports.
The browser you are using to browse this website is outdated and some features may not display properly or be accessible to you. Please use a more recent browser for the best user experience.